The White House has unveiled a significant agreement with pharmaceutical companies Eli Lilly and Novo Nordisk that will substantially alter the landscape of obesity...
A recent study has revealed that approximately half of patients using the weight loss drug semaglutide without diabetes discontinue treatment within a year. This...